Caribou Biosciences, INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ

26 Apr 2025

CRBU

SCHEDULE 13D: Caribou Biosciences CEO and Family Trust Increase Stake to 5%, Signaling Confidence

Caribou Biosciences, Inc. CEO Rachel E. Haurwitz and The City Canyon Family Trust have increased their beneficial ownership in the company to 5%, reflecting a renewed significant insider stake.